AIGH Capital Mgmt. Holds 2.66M Shares of Cellectar Biosciences

TL;DR

**AIGH Capital Management still owns 2.66 million shares of CLRB, signaling continued interest.**

AI Summary

AIGH Capital Management, LLC filed an amended Schedule 13G/A on February 7, 2024, indicating they beneficially own 2,662,324 shares of Cellectar Biosciences, Inc. common stock as of January 23, 2024. This represents a significant ownership stake, giving AIGH Capital Management considerable influence over the company's direction. For investors, this means a major institutional holder has a vested interest in the company's performance, which could signal confidence or potential for future strategic moves.

Why It Matters

This filing shows a significant institutional investor, AIGH Capital Management, LLC, maintains a substantial stake in Cellectar Biosciences, Inc., which can influence corporate decisions and investor sentiment.

Risk Assessment

Risk Level: low — This filing is an amendment to a previous ownership disclosure and doesn't indicate any immediate negative or positive financial events, but rather a confirmation of a significant stake.

Analyst Insight

Investors should note that a major institutional investor maintains a significant position, suggesting continued oversight and potential influence on Cellectar Biosciences. This could be a positive signal, but further research into AIGH Capital Management's history with similar investments and Cellectar's fundamentals is warranted.

Key Numbers

• 2,662,324 — Shares Beneficially Owned (Represents the total number of Cellectar Biosciences, Inc. common stock shares AIGH Capital Management, LLC has sole voting and dispositive power over.)
• January 23, 2024 — Date of Event (The specific date that triggered the requirement for this amendment filing.)
• 15117F807 — CUSIP Number (Unique identification number for Cellectar Biosciences, Inc. common stock.)

Key Players & Entities

• AIGH Capital Management, LLC (company) — Reporting Person, beneficial owner of shares
• Cellectar Biosciences, Inc. (company) — Issuer of the securities
• Orin Hirschman (person) — Filed by, associated with AIGH Capital Management, LLC
• 03 Life Sciences (company) — Organization name associated with the subject company

Forward-Looking Statements

• AIGH Capital Management, LLC will maintain its significant stake in Cellectar Biosciences, Inc. for the foreseeable future. (AIGH Capital Management, LLC) — medium confidence, target: 2025-02-07

FAQ

Key Financial Figures

• $0.00001 — INC (Name of Issuer) Common Stock, $0.00001 par value (Title of Class of Securiti

Filing Documents

• formsc13ga.htm (SC 13G/A) — 93KB
• 0001493152-24-005340.txt ( ) — 94KB

(a) above and Item 4 of each cover page

Item 2(a) above and Item 4 of each cover page. (d) Title of Class of Securities: Common Stock, $0.00001 par value (e) CUSIP Number: 15117F807 ITEM 3: IF THIS STATEMENT IS FILED PURSUANT TO §§240.13D-1(B) OR 240.13D-2(B) OR (C), CHECK WHETHER THE PERSON FILING IS A: (a) Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o); (b) Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c); (c) Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c); (d) Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C 80a-8); (e) An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E); (f) An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F); (g) A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G); (h) A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813); (i) A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3); (j) A non-U.S. institution, in accordance with §240.13d-1(b)(1)(ii)(J); (k) Group, in accordance with §240.13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with §240.13d-1(b)(1)(ii)(J), please specify the type of institution: ___________________________. ITEM 4: OWNERSHIP. See Item s 5,6,7,8 and 9 of each cover page. ITEM 5: OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS. If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following ITEM 6: OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON. Not applicable. ITEM 7: IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE SECURITY

View Full Filing

View this SC 13G/A filing on SEC EDGAR